ConductScience.org, home

Paper12975604

Role of perlecan in skeletal development and diseases.

Hassell J and 2 others. Glycoconj J, 2002. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Role of perlecan in skeletal development and diseases. Papers, record 12975604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12975604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of perlecan in skeletal development and diseases.
PubMed
Journal
Glycoconj J
PubMed
Year
2002
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.08
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hassell JJohn
2Yamada YYoshihiko
3Arikawa-Hirasawa EEri

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CartilageMajor topic
Heparan Sulfate ProteoglycansMajor topic
Animals
Bone Diseases, Developmental
Humans
Mice
Mice, Knockout
Molecular Structure
Mutation
Neuromuscular Junction
Osteochondrodysplasias

Source PubMed

Download CSV of topics

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18626565The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.J Biol Chem1996https://conductscience.org/library/papers/8626565PubMed
211389830Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1.Cell2001https://conductscience.org/library/papers/11389830PubMed
36449008Isolation of a heparan sulfate-containing proteoglycan from basement membrane.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6449008PubMed
48034692Amino acid determinants that drive heparan sulfate assembly in a proteoglycan.J Biol Chem1994https://conductscience.org/library/papers/8034692PubMed
510579729Perlecan maintains the integrity of cartilage and some basement membranes.J Cell Biol1999https://conductscience.org/library/papers/10579729PubMed
63917944Mechanisms of chain initiation in the biosynthesis of connective tissue polysaccharides.Fed Proc1985https://conductscience.org/library/papers/3917944PubMed
711356148UNC-52/perlecan isoform diversity and function in Caenorhabditis elegans.Biochem Soc Trans2001https://conductscience.org/library/papers/11356148PubMed
89030592Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element.J Biol Chem1997https://conductscience.org/library/papers/9030592PubMed
910330416Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan.J Cell Biol1999https://conductscience.org/library/papers/10330416PubMed
109431988The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.Eur J Biochem1997https://conductscience.org/library/papers/9431988PubMed
1110579711Life without perlecan has its problems.J Cell Biol1999https://conductscience.org/library/papers/10579711PubMed
122972708Identification of cDNA clones encoding different domains of the basement membrane heparan sulfate proteoglycan.J Biol Chem1988https://conductscience.org/library/papers/2972708PubMed
139020150Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis.J Biol Chem1997https://conductscience.org/library/papers/9020150PubMed
1411847221Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors.J Biol Chem2002https://conductscience.org/library/papers/11847221PubMed
151744087
The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule.
J Biol Chem1991https://conductscience.org/library/papers/1744087PubMed
168851045Supramolecular assembly of basement membranes.Bioessays1996https://conductscience.org/library/papers/8851045PubMed
1710571691Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice.J Bone Miner Res1999https://conductscience.org/library/papers/10571691PubMed
1810092882Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.Eur J Biochem1999https://conductscience.org/library/papers/10092882PubMed
196480700Extracellular matrix organization in developing muscle: correlation with acetylcholine receptor aggregates.J Cell Biol1984https://conductscience.org/library/papers/6480700PubMed
208601314Fibroblast growth factor receptor 3 is a negative regulator of bone growth.Cell1996https://conductscience.org/library/papers/8601314PubMed

See all 64 referencesDownload CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
39184370Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy.Proteoglycan Res2024https://conductscience.org/library/papers/39184370PubMed
37582915Spatial transcriptomics reveal markers of histopathological changes in Duchenne muscular dystrophy mouse models.Nat Commun2023https://conductscience.org/library/papers/37582915PubMed
35216048
Regulation of FGF-2, FGF-18 and Transcription Factor Activity by Perlecan in the Maturational Development of Transitional Rudiment and Growth Plate Cartilages and in the Maintenance of Permanent Cartilage Homeostasis.
Int J Mol Sci2022https://conductscience.org/library/papers/35216048PubMed
34982945Extracellular matrix guidance of autophagy: a mechanism regulating cancer growth.Open Biol2022https://conductscience.org/library/papers/34982945PubMed
33678174Knockdown of hspg2 is associated with abnormal mandibular joint formation and neural crest cell dysfunction in zebrafish.BMC Dev Biol2021https://conductscience.org/library/papers/33678174PubMed
33020183Angiostatic cues from the matrix: Endothelial cell autophagy meets hyaluronan biology.J Biol Chem2020https://conductscience.org/library/papers/33020183PubMed
31968632Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia.Int J Mol Sci2020https://conductscience.org/library/papers/31968632PubMed
27613501A current view of perlecan in physiology and pathology: A mosaic of functions.Matrix Biol2017https://conductscience.org/library/papers/27613501PubMed
26518982Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers.Adv Drug Deliv Rev2016https://conductscience.org/library/papers/26518982PubMed
25255879Mechanisms of otoconia and otolith development.Dev Dyn2015https://conductscience.org/library/papers/25255879PubMed
24001398Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.Matrix Biol2014https://conductscience.org/library/papers/24001398PubMed
23510717The proteoglycan Trol controls the architecture of the extracellular matrix and balances proliferation and differentiation of blood progenitors in the Drosophila lymph gland.Dev Biol2013https://conductscience.org/library/papers/23510717PubMed
20803598Expression, functional, and structural analysis of proteins critical for otoconia development.Dev Dyn2010https://conductscience.org/library/papers/20803598PubMed
20690028Comparative immunolocalisation of perlecan with collagen II and aggrecan in human foetal, newborn and adult ovine joint tissues demonstrates perlecan as an early developmental chondrogenic marker.Histochem Cell Biol2010https://conductscience.org/library/papers/20690028PubMed
19466598Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis.Mol Cells2009https://conductscience.org/library/papers/19466598PubMed
19422911Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.Matrix Biol2009https://conductscience.org/library/papers/19422911PubMed
19382872Perlecan domain IV peptide stimulates salivary gland cell assembly in vitro.Tissue Eng Part A2009https://conductscience.org/library/papers/19382872PubMed
18826258Diverse cell signaling events modulated by perlecan.Biochemistry2008https://conductscience.org/library/papers/18826258PubMed
18426981A central function for perlecan in skeletal muscle and cardiovascular development.J Cell Biol2008https://conductscience.org/library/papers/18426981PubMed
18300285Novel interactions of perlecan: unraveling perlecan's role in angiogenesis.Microsc Res Tech2008https://conductscience.org/library/papers/18300285PubMed

See all 29 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12975604

GET https://conductscience.org/api/papers/v1/12975604/references?page=2